Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONN
3951
CALL
DELISTED
Conn's Inc.
CONN
| $465K | ﹤0.01% |
14,100
+4,100
| +41% | +$118K |
|
3952
Atlantic Union Bankshares
AUB
$5.93B
| $464K | ﹤0.01% |
11,933
-7,099
| -37% | -$280K |
|
3953
PUT
Brunswick
BC
$5.28B
| $464K | ﹤0.01% |
7,200
+5,200
| +260% | +$325K |
|
3954
Weis Markets
WMK
$1.86B
| $463K | ﹤0.01% |
8,691
+6,704
| +337% | +$331K |
|
|
ALEX
3955
DELISTED
Alexander & Baldwin
ALEX
| $462K | ﹤0.01% |
19,638
-519
| -3% | -$11.5K |
|
3956
PUT
Kinross Gold
KGC
$32.8B
| $462K | ﹤0.01% |
123,000
-22,900
| -16% | -$86K |
|
3957
iShares Russell 2000 Value ETF
IWN
$14.6B
| $460K | ﹤0.01% |
3,482
+2,120
| +156% | +$273K |
|
3958
CALL
Myriad Genetics
MYGN
$312M
| $460K | ﹤0.01% |
12,300
-33,400
| -73% | -$1.13M |
|
|
SNV
3959
CALL
DELISTED
Synovus
SNV
| $460K | ﹤0.01% |
8,700
+1,100
| +14% | +$58.5K |
|
|
VIVO
3960
DELISTED
Meridian Bioscience Inc
VIVO
| $460K | ﹤0.01% |
28,886
-1,606
| -5% | -$24K |
|
3961
CALL
GoDaddy
GDDY
$11.5B
| $459K | ﹤0.01% |
6,500
-23,500
| -78% | -$1.6M |
|
3962
Karyopharm Therapeutics
KPTI
$48M
| $459K | ﹤0.01% |
1,803
-1,063
| -37% | -$263K |
|
|
NOAH
3963
Noah Holdings
NOAH
$603M
| $459K | ﹤0.01% |
+8,800
| New | +$498K |
|
3964
CALL
Synaptics
SYNA
$4.15B
| $458K | ﹤0.01% |
9,100
-8,000
| -47% | -$363K |
|
3965
Team
TISI
$77.7M
| $457K | ﹤0.01% |
1,979
+1,055
| +114% | +$203K |
|
3966
CALL
Zimmer Biomet
ZBH
$18.4B
| $457K | ﹤0.01% |
4,223
-7,828
| -65% | -$852K |
|
|
ONCE
3967
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $457K | ﹤0.01% |
5,512
-10,559
| -66% | -$815K |
|
3968
Gyre Therapeutics
GYRE
$744M
| $454K | ﹤0.01% |
5,186
+4,795
| +1,226% | +$841K |
|
3969
HealthStream
HSTM
$839M
| $454K | ﹤0.01% |
16,584
+7,140
| +76% | +$189K |
|
|
DBD
3970
DELISTED
Diebold Nixdorf Incorporated
DBD
| $454K | ﹤0.01% |
37,903
-32,636
| -46% | -$437K |
|
|
CERN
3971
PUT
DELISTED
Cerner Corp
CERN
| $454K | ﹤0.01% |
7,600
-36,900
| -83% | -$2.18M |
|
3972
Goldgroup Mining Inc.
GORO
$191M
| $453K | ﹤0.01% |
68,720
+26,921
| +64% | +$151K |
|
|
NPKI
3973
NPK International
NPKI
$1.14B
| $453K | ﹤0.01% |
41,773
+11,438
| +38% | +$116K |
|
3974
PUT
KBR
KBR
$4.8B
| $452K | ﹤0.01% |
25,200
+19,200
| +320% | +$334K |
|
3975
Marcus & Millichap
MMI
$1.19B
| $452K | ﹤0.01% |
11,578
-23,687
| -67% | -$874K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.